David T. Conner

Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally-active, nonulcerogenic antiinflammatory agents.

R. D. Dyer, M. D. Mullican, M. Wilson, 1993, Journal of medicinal chemistry.